There is variable data on mycophenolate use compared to azathioprine, but with an overall trend towards favoring MMF over AZA for prevention of ACR [ 41 ], CLAD, and a small amount of data favoring improved lung function. 3.2.3.
← all excerpts
Updates, Management, and Future of Diagnosing and Managing Chronic Lung Allograft Dysfunction.
1
—
—